The University of Chicago Header Logo

Connection

Lynne Kaminer to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Lynne Kaminer has written about Cost-Benefit Analysis.
Lynne Kaminer
Connection Strength
0.008
Cost-Benefit Analysis
  1. Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490). Ann Oncol. 1999 Feb; 10(2):177-82.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.